“Embedded in Lupin is a formula for growth which fuels creativity, performance and innovation”
It was Dr. Desh Bandhu Gupta’s vision and passion which helped him grow a small dream into a large company with a global footprint.
The most advanced pharmaceutical product development
Developing new chemical entities for focused therapy areas
Producing quality medicines in areas of unmet needs
Producing high quality affordable and accessible biologics
Financial Result
Share Capital
Press Releases
Press Kit
BSE -
NSE -
At Lupin, Corporate Governance has been an integral part of the way we conduct business. Good governance practices which are pre-requisite for attaining sustainable growth are embedded in our culture.
Corporate Governance is about doing the ‘right things’ in the ‘right manner’ at the ‘right time’ and Lupin remains committed to set the highest governance standards in form letter and spirit.
The Directors of the Company are well-known experts in their fields with a wide range of skills and expertise.
The Board has a balanced combination of executive, non-executive and independent directors which includes three women directors.
The Company promotes a culture of open deliberations, transparency and impartiality and does not tolerate corrupt and immoral practices. The Company adheres to the well-accepted norms of ethical, moral and legal conduct in its business operations.
As a testament of its robust corporate governance practices and ethical conduct of business, the Company instituted P.L.E.D.G.E. (Preparing Lupin Employees to Demonstrate Governance and Ethical Conduct), which enforces a common code of ethics, empowers employees to report unethical practices, ensures swift redressal and institutes specific mechanisms to deal with workplace harassment.
Lupin is in compliance with SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 on Corporate Governance.